This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global and the Oncology Brothers do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLOSURES OF RELEVANT FINANCIAL RELATIONSHIPS
Global adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by Joint Accreditation and all other accrediting bodies, as applicable,stating those activities where CE credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited CE program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months. All financial relationships reported are appropriately identified as relevant by Global. All relevant financial relationships have been mitigated in advance of delivery of the activity to learners.
A full list of disclosure information for all persons in control of content for the program will be provided during the conference.
LEARNING OBJECTIVES
Coming soon
Program Overview
Practical oncology education for real clinical decisions
Join practicing hematologists, oncologists, advanced practice providers, and fellows for case-based updates focused on cancer care advances, molecular testing, adverse event management, and treatment selection.
To secure the group rate, reservations must be made by June 8, 2027. Rooms are subject to availability.
Accreditation
Designed for continuing oncology education
In support of improving patient care, this activity has been planned and implemented by Global Education Group and the Oncology Brothers. Global Education Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Jointly accredited continuing education
Physician Credit Designation - 8 contact hours
Global Education Group designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credits™.
Nurse Contact Hours Designation - 8 contact hours
Global Education Group designates this continuing education activity for 8.0 contact hour(s) including 0.0 pharmacotherapeutic contact hour(s).
Pharmacist Credit Designation - 8 contact hours
Global Education Group designates this continuing education activity for 8.0 contact hour(s) (0.8 CEUs). (Universal Activity Number - JA0007169-9999-27-001-L01-P). This is an application-based activity.
Who Should Attend
Target Audience
This educational activity is designed for medical oncologists, hematologic oncologists, community and academic oncologists, oncology nurses, pharmacists, and other advanced practice providers involved in the care of patients with cancer.
Registration
Fee Information
There is no registration fee for attending the symposium. Seating is limited, and pre-registration does not guarantee a seat, so early arrival is recommended.
Event Information
Support, contact, and privacy details
Helpful attendee information for accessibility requests, accreditation questions, and privacy practices.
Americans with Disabilities Act
Event staff will be glad to assist with special needs, including physical, dietary, or accessibility requests.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.